Sabby Management, LLC Baudax Bio, Inc. Transaction History

Sabby Management, LLC

  • $1.52 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$0.26 - $0.87 $101,946 - $341,129
392,103 Added 832.19%
439,220 $108,000
Q2 2022

Aug 15, 2022
BUY
$0.68 - $1.87 $19,187 - $52,765
28,217 Added 149.3%
47,117 $40,000
Q1 2022

May 16, 2022
BUY
$1.58 - $8.47 $29,862 - $160,083
18,900 New
18,900 $33,000

About Baudax Bio, Inc.

BXRX Quotes by TradingView
  • Ticker BXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,003,700
  • Market Cap $200K
  • Description
  • Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with non-NSAID analgesics. Its products under development includes BX1000, an intermediate-acting neuro...
More about BXRX
Track This Portfolio

Track Sabby Management, LLC Portfolio

Follow Sabby Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sabby Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email